Alexander Juto

Artiklar

Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2020;37:101468

Interrupting rituximab treatment in relapsing-remitting multiple sclerosis; no evidence of rebound disease activity

Juto A; Fink K; Al Nimer F; Piehl F
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2019;26(8):1060-1067

Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis

Boremalm M; Juto A; Axelsson M; Novakova L; Frisell T; Svenningsson A; Lycke J; Piehl F; Selzer J
Article: MULTIPLE SCLEROSIS JOURNAL. 2018;24(9):1224-1233

Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies

Dunn N; Juto A; Ryner M; Manouchehrinia A; Piccoli L; Fink K; Piehl F; Fogdell-Hahn A
Article: ACTA OTO-LARYNGOLOGICA. 2017;137(8):850-855

Kinetic oscillatory stimulation of nasal mucosa in non-allergic rhinitis: comparison of patient self-administration and caregiver administration regarding pain and treatment effect. A randomized clinical trial

Juto A; Juto AJ; von Hofsten P; Jorgensen F

Medicine Doktorsexamen, Institutionen för klinisk neurovetenskap, Karolinska Institutet, 2021